These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain. Van Laere K; Ahmad RU; Hudyana H; Dubois K; Schmidt ME; Celen S; Bormans G; Koole M J Nucl Med; 2013 Aug; 54(8):1285-93. PubMed ID: 23843566 [TBL] [Abstract][Full Text] [Related]
24. Quantification of Tau Load Using [ Golla SSV; Timmers T; Ossenkoppele R; Groot C; Verfaillie S; Scheltens P; van der Flier WM; Schwarte L; Mintun MA; Devous M; Schuit RC; Windhorst AD; Lammertsma AA; Boellaard R; van Berckel BNM; Yaqub M Mol Imaging Biol; 2017 Dec; 19(6):963-971. PubMed ID: 28374171 [TBL] [Abstract][Full Text] [Related]
25. Quantification of TSPO overexpression in a rat model of local neuroinflammation induced by intracerebral injection of LPS by the use of [(18)F]DPA-714 PET. Ory D; Postnov A; Koole M; Celen S; de Laat B; Verbruggen A; Van Laere K; Bormans G; Casteels C Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):163-172. PubMed ID: 26323575 [TBL] [Abstract][Full Text] [Related]
26. Implementation and validation of an adaptive template registration method for 18F-flutemetamol imaging data. Lundqvist R; Lilja J; Thomas BA; Lötjönen J; Villemagne VL; Rowe CC; Thurfjell L J Nucl Med; 2013 Aug; 54(8):1472-8. PubMed ID: 23740104 [TBL] [Abstract][Full Text] [Related]
27. Optimal Acquisition Time Window and Simplified Quantification of Dopamine Transporter Availability Using 18F-FE-PE2I in Healthy Controls and Parkinson Disease Patients. Sonni I; Fazio P; Schain M; Halldin C; Svenningsson P; Farde L; Varrone A J Nucl Med; 2016 Oct; 57(10):1529-1534. PubMed ID: 27230923 [TBL] [Abstract][Full Text] [Related]
28. Preliminary Assessment of Reference Region Quantification and Reduced Scanning Times for [ Smart K; Uribe C; Desmond KL; Martin SL; Vasdev N; Strafella AP Mol Imaging; 2023; 2023():1855985. PubMed ID: 37622164 [TBL] [Abstract][Full Text] [Related]
29. Reference Tissue-Based Kinetic Evaluation of 18F-AV-1451 for Tau Imaging. Baker SL; Lockhart SN; Price JC; He M; Huesman RH; Schonhaut D; Faria J; Rabinovici G; Jagust WJ J Nucl Med; 2017 Feb; 58(2):332-338. PubMed ID: 27587706 [TBL] [Abstract][Full Text] [Related]
30. Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: concordance with visual image reads. Thurfjell L; Lilja J; Lundqvist R; Buckley C; Smith A; Vandenberghe R; Sherwin P J Nucl Med; 2014 Oct; 55(10):1623-8. PubMed ID: 25146124 [TBL] [Abstract][Full Text] [Related]
31. Investigation of the quantitative accuracy of low-dose amyloid and tau PET imaging. Nai YH; Watanuki S; Tashiro M; Okamura N; Watabe H Radiol Phys Technol; 2018 Dec; 11(4):451-459. PubMed ID: 30328073 [TBL] [Abstract][Full Text] [Related]
32. Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology. Jonasson M; Wall A; Chiotis K; Saint-Aubert L; Wilking H; Sprycha M; Borg B; Thibblin A; Eriksson J; Sörensen J; Antoni G; Nordberg A; Lubberink M J Nucl Med; 2016 Apr; 57(4):574-81. PubMed ID: 26795290 [TBL] [Abstract][Full Text] [Related]
33. Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study. Barthel H; Gertz HJ; Dresel S; Peters O; Bartenstein P; Buerger K; Hiemeyer F; Wittemer-Rump SM; Seibyl J; Reininger C; Sabri O; Lancet Neurol; 2011 May; 10(5):424-35. PubMed ID: 21481640 [TBL] [Abstract][Full Text] [Related]
34. Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection. Ikonomovic MD; Buckley CJ; Heurling K; Sherwin P; Jones PA; Zanette M; Mathis CA; Klunk WE; Chakrabarty A; Ironside J; Ismail A; Smith C; Thal DR; Beach TG; Farrar G; Smith AP Acta Neuropathol Commun; 2016 Dec; 4(1):130. PubMed ID: 27955679 [TBL] [Abstract][Full Text] [Related]
35. Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects. Mountz JM; Laymon CM; Cohen AD; Zhang Z; Price JC; Boudhar S; McDade E; Aizenstein HJ; Klunk WE; Mathis CA Neuroimage Clin; 2015; 9():592-8. PubMed ID: 26640770 [TBL] [Abstract][Full Text] [Related]
36. Kinetic Modeling of the Tau PET Tracer Barret O; Alagille D; Sanabria S; Comley RA; Weimer RM; Borroni E; Mintun M; Seneca N; Papin C; Morley T; Marek K; Seibyl JP; Tamagnan GD; Jennings D J Nucl Med; 2017 Jul; 58(7):1124-1131. PubMed ID: 27908967 [No Abstract] [Full Text] [Related]